Elsevier

Neuropharmacology

Volume 39, Issue 3, March 2000, Pages 482-496
Neuropharmacology

P2Y receptors contribute to ATP-induced increases in intracellular calcium in differentiated but not undifferentiated PC12 cells

https://doi.org/10.1016/S0028-3908(99)00141-0Get rights and content

Abstract

ATP-induced Ca2+ transients were examined in individual PC12 cells of a well defined clone, before and after treatment with nerve growth factor (NGF) to induce a neurone-like phenotype. Using reverse transcriptase PCR these cells were found to express mRNA for several P2 receptors. In undifferentiated cells the ATP-induced Ca2+ response was entirely dependent on Ca2+ influx, could not be mimicked by UTP, α,β-methylene ATP or dibenzoyl ATP or be blocked by pyridoxalphosphate-6-azophenyl-2′,4′-disulphonic acid (PPADS). ATP had no significant effect on levels of cyclic AMP or inositol 1,4,5-trisphosphate (InsP3). These results suggest that in undifferentiated PC12 cells ATP mainly acts on a P2X receptor, possibly the P2X4 subtype. After treatment with NGF for 7 days the ATP response was increased and partially sensitive to PPADS. A component of the ATP-induced Ca2+ increase was due to mobilisation of intracellular Ca2+ stores and another to capacitative Ca2+ entry. UTP caused an increase in intracellular Ca2+, and InsP3 formation could be stimulated by ATP and UTP. ATP also caused a small increase in cyclic AMP, but this was abolished in the presence of indomethacin. Thus, after NGF treatment ATP acts partially via a P2Y receptor, possibly the P2Y2 subtype.

Introduction

PC12 cells, derived from a spontaneous rat phaeochromocytoma (Greene and Tischler, 1976), are widely used to study e.g. neuronal differentiation, effects of growth factors and regulation of neurotransmitter release (Greene et al., 1991). We have compared ATP-induced Ca2+ transients in undifferentiated and in nerve growth factor (NGF)-differentiated cells (Greene et al., 1991) to determine if the response to ATP is modified with the phenotype of PC12 cells.

Extracellular ATP and related nucleotides are known to influence most cells via activation of cell membrane receptors (see Ralevic and Burnstock, 1998). These receptors belong to two different families: G protein coupled P2Y receptors and transmitter gated ion channels, P2X receptors (Ralevic and Burnstock, 1998). Both P2Y receptors and P2X receptors are known to increase intracellular Ca2+ levels. P2Y receptors act by stimulating Gq/11 proteins, by mobilising Ca2+ from intracellular depots, and by permitting influx via specific receptor-operated channels (Dubyak and el-Moatassim, 1993, Clementi and Meldolesi, 1996). P2X receptors increase intracellular Ca2+ levels by allowing Ca2+ ions to pass through the opened channel along the ionic gradient (see Ralevic and Burnstock, 1998). The pharmacological characterisation of the receptor(s) responsible for mediating increases in intracellular Ca2+ in tissues and cells has been complicated by the fact that there are few selective antagonists and that multiple receptor subtypes may co-exist in tissues and cells (Ralevic and Burnstock, 1998).

ATP has been shown to increase cytosolic Ca2+ (Fasolato et al., 1990) in PC12 cells via different mechanisms: opening of a receptor-operated channel (Fasolato et al., 1990, Michel et al., 1996), activation of phospholipase C (Murrin and Boarder, 1992) and opening of voltage sensitive Ca2+ channels secondarily to an ATP mediated depolarisation (Fasolato et al., 1990). These data have been replicated many times, but there are often marked quantitative differences between the results of different studies. Not only do the conditions under which PC12 cells are cultured differ between laboratories, but these cells are notorious for their ability to change their phenotype, both when cultured with differentiating factors and spontaneously (Greene et al., 1991). We have therefore examined the effects of NGF-induced differentiation in a clone of PC12 cells that was isolated based on neomycin resistance (clone 1 in the original article) (Zacchetti et al., 1991, Clementi et al., 1992b). This clone shows a rather stable genotype and has proven useful in studies of Ca2+ movements (Fasolato et al., 1991, Zacchetti et al., 1991) as well as gene and marker expression (Clementi et al., 1992a). Since a major aim was to determine if responses to ATP could be due to activation of more than one type of receptor in a PC12 cell we have performed the studies mostly on single cells. Our results indicate that in differentiated PC12 cells both P2X and P2Y receptors contribute to the Ca2+ response, whereas in undifferentiated PC12 cells ATP-induced effects are only mediated via P2X receptors.

Section snippets

Materials

Cell culture media, foetal calf and horse serum, and cell culture flasks were obtained from NordCell (Bromma, Sweden). Mouse 2.5S nerve growth factor (NGF) was obtained from Promega, Madison, WI, USA. d-myo-2-[3H] Inositol 1,4,5-trisphosphate (InsP3) and 2,8-[3H] adenosine 3′,5′-cyclic monophosphate (cAMP) were obtained from Amersham (Little Chalfont, UK). Fura-2 free acid and Fura 2-AM were obtained from Molecular Probes, Eugene, OR, USA. Bradykinin, indomethacin, ATP, ADP, UTP, α,β-methylene

Presence of both P2Y and P2X receptor mRNA in PC12 clone 1 cells

We first screened control and differentiated cells using RT-PCR with primers for P2X and P2Y receptors. Transcripts amplified by several of the primers (Table 1, Table 2) were detected in both cell samples (Fig. 1).

In undifferentiated PC12 cells, bands corresponding to mRNA for P2X1, P2X2, P2X3, P2X4 and P2X5, but not P2X6, were present. The P2X2 primers generated an additional band, which is probably due to the presence of mRNA for a splice variant of this receptor, the P2X2b receptor (Simon

Discussion

Our aim was to study responses to ATP in one well characterised PC12 cell clone and to find out whether NGF differentiation could lead to a modification of the P2 receptor(s) expressed. The major finding is that differentiation of PC12 cells by NGF led to quantitative and qualitative differences in the ATP-induced Ca2+ transients. Thus, the response was larger and showed a less complete dependence on extracellular Ca2+ in PC12 cells treated with NGF for 1 week. In addition, the response to ATP

Acknowledgements

The present studies were supported by the Swedish Medical Research Council (project Nos. 14X-2553 and 14XS-12707) and by Wallenberg Stiftelsen. C.M.F. was partially supported by a grant from Perstorp Pharma (Lund, Sweden) to Prof. D.D. Branisteanu. We would like to thank Dr. Hiltrud Schaedlic for carrying out the PCR studies for the P2X receptors and Janet Holmén for critical reading of the manuscript.

References (37)

  • G. Grynkiewicz et al.

    A new generation of Ca2+ indicators with greatly improved fluorescence properties

    Journal of Biological Chemistry

    (1985)
  • G.J. McLaren et al.

    Comparison of the actions of ATP and UTP and P(2X1) receptors in smooth muscle of the rat tail artery

    European Journal of Pharmacology

    (1998)
  • C. Nordstedt et al.

    A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid

    Analytical Biochemistry

    (1990)
  • G.E. Torres et al.

    Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners

    Journal of Biological Chemistry

    (1999)
  • Y. Yakushi et al.

    P2 purinoceptor-mediated stimulation of adenylyl cyclase in PC12 cells

    European Journal of Pharmacology

    (1996)
  • D. Zacchetti et al.

    Intracellular Ca2+ pools in PC12 cells. A unique, rapidly exchanging pool is sensitive to both inositol 1,4,5-trisphosphate and caffeine-ryanodine

    Journal of Biological Chemistry

    (1991)
  • G. Arslan et al.

    Signaling via A2A adenosine receptor in four PC12 cell clones

    Naunyn-Schmiedeberg's Archives of Pharmacology

    (1999)
  • Y.D. Bogdanov et al.

    Molecular cloning and characterization of rat P2Y4 nucleotide receptor

    British Journal of Pharmacology

    (1998)
  • Cited by (50)

    • Non-nutritional uses of nutrients

      2011, European Journal of Pharmacology
      Citation Excerpt :

      The brain enzyme that controls the overall rate at which the nutrient is converted to its pharmacologically-active product must also be unsaturated with substrate, and capable of generating more product when brain levels of its substrate rise. This is indeed the case for the acetyltransferase enzyme that converts choline to the neurotransmitter acetylcholine (Blusztajn and Wurtman, 1983); or the kinases that phosphorylate uridine (Cansev, 2006; Skold, 1960) to form the P2Y receptor agonists (Arslan et al., 2000; Burnstock, 2007) UDP or UTP; or the enzyme that hydroxylates tryptophan (Hufton et al., 1995) to form 5-hydroxytryptophan, an intermediate in serotonin synthesis ; or the enzymes that control the conversion of tyrosine, glutamine, threonine, or glutamine to their neurotransmitter products, described above. The activity of tyrosine hydroxylase, the enzyme in catecholaminergic nerve terminals that hydroxylates tyrosine to form dopa and, subsequently, dopamine or norepinephrine, may or may not be affected by tissue tyrosine levels, depending on its own state of phosphorylation: If the neuron has been quiescent, the activity of its tyrosine hydroxylase is limited by the enzyme's poor saturation with tetrahydrobiopterin, its cofactor (Lovenberg et al., 1975); however when the neuron fires repeatedly, the enzyme becomes phosphorylated, causing its cofactor affinity to rise several hundredfold and its net activity to depend instead on its saturation with tyrosine (Melamed et al., 1980; Wurtman et al., 1974).

    • ADP ribose is an endogenous ligand for the purinergic P2Y1 receptor

      2011, Molecular and Cellular Endocrinology
      Citation Excerpt :

      The inhibition of ADPr-induced [Ca2+]i increase by two structurally different selective antagonists of the P2Y1 receptor, is strong evidence for the involvement of the P2Y1 receptor in ADPr-induced [Ca2+]i increase. We also demonstrated that ADPr did not increase [Ca2+]i in undifferentiated PC12 cells, a cell type that lacks P2Y1 receptors, providing further evidence that ADPr increased [Ca2+]i by activating the P2Y1 receptors (Arslan et al., 2000; Moskvina et al., 2003). From previous studies, it is established that in addition to P2Y1, several other purinergic receptors, namely P2Y2, P2Y4, P2Y6 and P2Y12 are expressed in pancreatic β-cells (Lugo-Garcia et al., 2007; Verspohl et al., 2002).

    • Pharmacological properties of purinergic receptors and their effects on proliferation and induction of neuronal differentiation of P19 embryonal carcinoma cells

      2008, International Journal of Developmental Neuroscience
      Citation Excerpt :

      We found that this purinergic receptor agonist was nearly twice as potent in inducing [Ca2+]i elevations in neuronal-differentiated than in undifferentiated P19 cells, suggesting the expression of functional P2X2 receptors by P19 neurons. In agreement, 2-MeS-ATP potency determined as the agonist concentration needed for half-maximal receptor activation (EC50) in P19 neuronal cells was similar to EC50 values reported for P2X2 receptors in differentiated PC12 cells (Arslan et al., 2000). The smaller potency of 2-MeS-ATP in inducing [Ca2+]i elevations in undifferentiated P19 cells indicates P2X4 but not P2X2 receptor activity, being in agreement with previous published data of purinergic receptor expression in P19 cells (Resende et al., 2007).

    View all citing articles on Scopus
    1

    Present address: Department of Clinical Pharmacology, University of Groningen, Faculty of Medical Sciences, A. Deusinglaan 1, 9713 AV Groningen, The Netherlands.

    View full text